Voltar
Artigo
BIBTEX RIS

Initial experience with bosentan (Tracleer®) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children

2005; Springer Science+Business Media; Volume: 94; Issue: 9 Linguagem: Inglês

10.1007/s00392-005-0266-6

ISSN

1435-1285

Autores

Nadine Gilbert, Yvonne-Christin Luther, Oliver Miera, Nicole Nagdyman, Peter Ewert, Felix Berger, Peter Lange, Ingram Schulze‐Neick,

Tópico(s)

Congenital Heart Disease Studies

Referência(s)